U.S. flag

An official website of the United States government

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Links from MedGen

Items: 1 to 20 of 365

1.
ANATOMICAL AND FUNCTIONAL OUTCOMES OF BEVACIZUMAB TREATMENT IN PEDIATRIC AUTOSOMAL RECESSIVE BESTROPHINOPATHY
Mitchell Jacobs, May El-Rashedy, Nicholas Fowler, Belinda Shirkey, John Kitchens, Ramiro S. Maldonado
Retin Cases Brief Rep. 2024 May; 18(3): 378–386. Published online 2023 Dec 7. doi: 10.1097/ICB.0000000000001390
PMCID:
PMC11027967
AbstractArticlePDF–967K
2.
A Review on Neuroinflammatory Pathway Mediating Through Ang-II/AT1 Receptors and a Novel Approach for the Treatment of Cerebral Ischemia in Combination with ARB’s and Ceftriaxone
Gaddam Narasimha Rao, Srikanth Jupudi, Antony Justin
Ann Neurosci. 2024 Jan; 31(1): 53–62. Published online 2023 Aug 18. doi: 10.1177/09727531231182554
PMCID:
PMC10996871
AbstractArticlePDF–1.3M
3.
Efficacy and safety of Abelmoschus manihot capsule combined with ACEI/ARB on diabetic kidney disease: a systematic review and meta analysis
Ying Tan, Ziqi Zhang, Peipei Zhou, Qiling Zhang, Nan Li, Qianhua Yan, Liji Huang, Jiangyi Yu
Front Pharmacol. 2023; 14: 1288159. Published online 2024 Jan 5. doi: 10.3389/fphar.2023.1288159
PMCID:
PMC10796716
AbstractArticlePDF–4.4M
4.
Long-term oral ACEI/ARB therapy is associated with disease severity in elderly COVID-19 omicron BA.2 patients with hypertension
Zhe Zhang, Shengyong Wu, Zhiyong Wang, Yue Wang, Hui Chen, Cheng Wu, Lize Xiong
BMC Infect Dis. 2023; 23: 882. Published online 2023 Dec 18. doi: 10.1186/s12879-023-08913-6
PMCID:
PMC10726588
AbstractArticlePDF–2.5M
5.
Management of Bevacizumab-Induced Proteinuria Using an Angiotensin Receptor Blocker (ARB) in a Neurofibromatosis Type 2 (NF-2) Patient With Vestibular Schwannoma
Egiroh E Omene, Jay Easaw
Cureus. 2023 Sep; 15(9): e46202. Published online 2023 Sep 29. doi: 10.7759/cureus.46202
PMCID:
PMC10613429
AbstractArticlePDF–275K
6.
ACEI/ARB and beta-blocker therapies for preventing cardiotoxicity of antineoplastic agents in breast cancer: a systematic review and meta-analysis
Yu Gao, Ruiting Wang, Jinchi Jiang, Yueyao Hu, Haijing Li, Yong Wang
Heart Fail Rev. 2023; 28(6): 1405–1415. Published online 2023 Jul 7. doi: 10.1007/s10741-023-10328-z
PMCID:
PMC10575808
AbstractArticlePDF–2.3M
7.
Comprehensive Genetic Analysis Unraveled the Missing Heritability and a Founder Variant of BEST1 in a Chinese Cohort With Autosomal Recessive Bestrophinopathy
Jie Shi, Lu Tian, Tengyang Sun, Xiao Zhang, Ke Xu, Yue Xie, Xiaoyan Peng, Xin Tang, Zi-Bing Jin, Yang Li
Invest Ophthalmol Vis Sci. 2023 Sep; 64(12): 37. Published online 2023 Sep 25. doi: 10.1167/iovs.64.12.37
PMCID:
PMC10528473
AbstractArticlePDF–6.7M
8.
ACE Inhibitor and ARB Utilization and Expenditures in the Medicaid Fee-For-Service Program from 1991 to 2008
Boyang Bian, Christina M.L. Kelton, Jeff J. Guo, Patricia R. Wigle
J Manag Care Pharm. 2010 Nov; 16(9): 10.18553/jmcp.2010.16.9.671. doi: 10.18553/jmcp.2010.16.9.671
PMCID:
PMC10437572
AbstractPDF–385K
9.
Text mining online disinformation about antihypertensive agents ACEI/ARB and COVID-19 on Sina Weibo
Chunli Wang, Bing Fang, Aksara Regmi, Yoshifumi Yamaguchi, Ling Yang, Yuyang Cai
J Glob Health. 2023; 13: 06028. Published online 2023 Aug 18. doi: 10.7189/jogh.13.06028
PMCID:
PMC10436343
AbstractArticlePDF–1.5M
10.
The efficacy and safety of sacubitril/valsartan compared with ACEI/ARB in the treatment of heart failure following acute myocardial infarction: a systematic review and meta-analysis of randomized controlled trials
Jinquan Gao, Xin Zhang, Mengzhuo Xu, Shisu Deng, Xiaoping Chen
Front Pharmacol. 2023; 14: 1237210. Published online 2023 Aug 4. doi: 10.3389/fphar.2023.1237210
PMCID:
PMC10436296
AbstractArticlePDF–2.0M
11.
Comparing clinical outcomes of ARB and ACEi in patients hospitalized for acute COVID-19
Seiji Hamada, Tomoharu Suzuki, Yasuharu Tokuda, Kiyosu Taniguchi, Kenji Shibuya
Sci Rep. 2023; 13: 11810. Published online 2023 Jul 21. doi: 10.1038/s41598-023-38838-8
PMCID:
PMC10361955
AbstractArticlePDF–802K
12.
Effects of ACEI/ARB or CCB use on atrial fibrillation in hypertensive patients following permanent pacemaker implantation
Zhijie Liu, Ning Bian, Shaorong Wu, Yantao Cao, Yiting Su, Wenying Li, Hairui Li, Xianwu Lan, Can Jiang, Yiming Fan, Jun Guo, Dongdong Chen
Front Cardiovasc Med. 2023; 10: 1191539. Published online 2023 Jun 22. doi: 10.3389/fcvm.2023.1191539
PMCID:
PMC10324512
AbstractArticlePDF–1.1M
13.
A collaborative study of the impact of N-nitrosamines presence and ARB recall on ARB utilization – results from IQVIA™ Disease Analyzer Germany
Karin Hedenmalm, Chantal Quinten, Xavier Kurz, Marie Bradley, Hana Lee, Efe Eworuke
Eur J Clin Pharmacol. 2023; 79(6): 849–858. Published online 2023 Apr 24. doi: 10.1007/s00228-022-03439-3
PMCID:
PMC10229727
AbstractArticlePDF–1.3M
14.
Clinical Impact of ACE-I/ARB for Conservatively Treated Patients with Moderate to Severe Mitral Regurgitation: A Single Center Observational Study
Robert Uzel, Raphael R. Bruno, Christian Jung, Christian Lang, Hannes Hoi, Martin Grünbart, Christian Datz, Friedrich Hoppichler, Bernhard Wernly
J Cardiovasc Dev Dis. 2023 Apr; 10(4): 177. Published online 2023 Apr 18. doi: 10.3390/jcdd10040177
PMCID:
PMC10142284
AbstractArticlePDF–653K
15.
Autosomal recessive bestrophinopathy combined with neurofibromatosis type 1 in a patient
Bo Zhao, Lian Chen, Peng Zhang, Ke He, Min Lei, Juan Zhang
BMC Ophthalmol. 2023; 23: 151. Published online 2023 Apr 11. doi: 10.1186/s12886-023-02905-5
PMCID:
PMC10088182
AbstractArticlePDF–1.3M
16.
The clinical efficacy of fluticasone propionate combined with ACEI/ARB in the treatment of immunoglobulin A nephropathy
Liping Sun, Xinyi Zi, Zhen Wang, Xinzhou Zhang
BMC Nephrol. 2023; 24: 63. Published online 2023 Mar 22. doi: 10.1186/s12882-023-03106-4
PMCID:
PMC10031945
AbstractArticlePDF–1.1M
17.
Bilateral Choroidal Neovascularization and Chorioretinal Anastomosis in Autosomal Recessive Bestrophinopathy
Youning Zhang, Jennifer Danesh, Kyle M. Green, Ryan J. Schmidt, Jaclyn Biegel, Xiaowu Gai, Thomas C. Lee, Amir H. Kashani, Aaron Nagiel
J Vitreoretin Dis. 2020 Jan-Feb; 4(1): 69–74. Published online 2019 Oct 17. doi: 10.1177/2474126419880383
PMCID:
PMC9976081
AbstractArticlePDF–678K
18.
Autosomal Recessive Bestrophinopathy Presenting With a Macular Hole Retinal Detachment
Yousef Ahmed Fouad, Caroline Atef Tawfik, Mohamed Nowara
J Vitreoretin Dis. 2022 Jul-Aug; 6(4): 312–315. Published online 2022 Jul 20. doi: 10.1177/24741264221098631
PMCID:
PMC9976030
AbstractArticlePDF–1.4M
19.
Real-world comparative effectiveness of ARNI versus ACEi/ARB in HF with reduced or mildly reduced ejection fraction
Michael Fu, Aldina Pivodic, Oskar Käck, Madlaina Costa-Scharplatz, Ulf Dahlström, Lars H. Lund
Clin Res Cardiol. 2023; 112(1): 167–174. Published online 2022 Nov 29. doi: 10.1007/s00392-022-02124-w
PMCID:
PMC9849288
AbstractArticlePDF–923K
20.
Systematic review and meta-analysis of the clinical outcomes of ACEI/ARB in East-Asian patients with COVID-19
Nancy Xurui Huang, Qi Yuan, Fang Fang, Bryan P. Yan, John E. Sanderson
PLoS One. 2023; 18(1): e0280280. Published online 2023 Jan 12. doi: 10.1371/journal.pone.0280280
PMCID:
PMC9836310
AbstractArticlePDF–3.4M

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Filter your results:

Find related data

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
You are here: NCBI > Literature > PubMed Central (PMC)
Support Center